Neurobiology of addiction: treatment and public policy ramifications (original) (raw)

References

1. MpcLellan, A.T., Lewis, D.C., O'Brien, C.P. & Kleber, H.D. J. Am. Med. Assoc. 284, 1689–1695 (2000).
   Google Scholar
2. Dackis, C.A. & O'Brien, C.P. J. Subst. Abuse Treat. 21, 111–117 (2001).
   CAS Google Scholar
3. Dackis, C.A. Drug Des. Discov. 2, 79–86 (2005).
   CAS Google Scholar
4. Belenka, S., Patapis, N. & French, M. Economic Benefits of Drug Treatment (National Rural Alcohol and Drug Abuse Network, Menominie, Wisconsin, 2005).
   Google Scholar
5. Weisner, C., Mertens, J., Parthasarathy, S., Moore, C. & Lu, Y. J. Am. Med. Assoc. 286, 1715–1723 (2001).
   CAS Google Scholar
6. Volkow, N.D., Fowler, J.S. & Wang, G.J. Neuropharmacology 47 (Suppl.) 3–13 (2004).
   CAS Google Scholar
7. Small, D.M., Jones-Gotman, M. & Dagher, A. Neuroimage 19, 1709–1715 (2003).
   Google Scholar
8. Dackis, C.A. & O'Brien, C.P. in Diseases of the Nervous System (eds. Asbury, A., McKhann, G., McDonald, W., Goadsby, P. & McArthur, J.) 431–444 (Cambridge Univ. Press, Cambridge, 2002).
   Google Scholar
9. Franklin, T.R. et al. Biol. Psychiatry 51, 134–142 (2002).
   CAS Google Scholar
10. Altshuler, H.L. et al. Pharmacol. Biochem. Behav. 13 Suppl 1, 233–240 (1980).
    CAS Google Scholar
11. Roberts, A.J. et al. J. Pharmacol. Exp. Ther. 293, 1002–1008 (2000).
    CAS Google Scholar
12. Gianoulakis, C., Krishnan, B. & Thavundayil, J. Arch. Gen. Psychiatry 53, 250–257 (1996).
    CAS Google Scholar
13. Genazzani, A.R. et al. J. Clin. Endocrinol. Metab. 55, 583–586 (1982).
    CAS Google Scholar
14. Vescovi, P.P., Coiro, V., Volpi, R., Giannini, A. & Passeri, M. Alcohol Alcohol. 27, 471–475 (1992).
    CAS Google Scholar
15. Heinz, A. et al. Arch. Gen. Psychiatry 62, 57–64 (2005).
    Google Scholar
16. Heinz, A. et al. Am. J. Psychiatry 161, 1783–1789 (2004).
    Google Scholar
17. Myrick, H. et al. Neuropsychopharmacology 29, 393–402 (2004).
    CAS Google Scholar
18. Grusser, S.M. et al. Psychopharmacology (Berl.) 175, 296–302 (2004).
    Google Scholar
19. Sell, L.A. et al. Drug Alcohol Depend. 60, 207–216 (2000).
    CAS Google Scholar
20. Brody, A.L. et al. Psychiatry Res. 130, 269–281 (2004).
    Google Scholar
21. Garavan, H. et al. Am. J. Psychiatry 157, 1789–1798 (2000).
    CAS Google Scholar
22. Wang, G.J. et al. Neuroimage 21, 1790–1797 (2004).
    Google Scholar
23. Schultz, W. Neuroscientist 7, 293–302 (2001).
    CAS Google Scholar
24. Rossetti, Z.L., Melis, F., Carboni, S. & Gessa, G.L. Ann. NY Acad. Sci. 654, 513–516 (1992).
    CAS Google Scholar
25. Dackis, C. & O'Brien, C. Ann. NY Acad. Sci. 1003, 328–345 (2003).
    CAS Google Scholar
26. Martinez, D. et al. Neuropsychopharmacology 29, 1190–1202 (2004).
    CAS Google Scholar
27. Volkow, N.D. et al. Am. J. Psychiatry 158, 2015–2021 (2001).
    CAS Google Scholar
28. Wang, G.J., Volkow, N.D., Thanos, P.K. & Fowler, J.S. J. Addict. Dis. 23, 39–53 (2004).
    Google Scholar
29. Morgan, D. et al. Nat. Neurosci. 5, 169–174 (2002).
    CAS Google Scholar
30. Thanos, P.K. et al. J. Neurochem. 78, 1094–1103 (2001).
    CAS Google Scholar
31. Czoty, P.W., Morgan, D., Shannon, E.E., Gage, H.D. & Nader, M.A. Psychopharmacology (Berl.) 174, 381–388 (2004).
    CAS Google Scholar
32. Georges, F. & Aston-Jones, G. Neuropsychopharmacology 28, 1140–1149 (2003).
    CAS Google Scholar
33. Gerrits, M.A., Petromilli, P., Westenberg, H.G., Di Chiara, G. & van Ree, J.M. Brain Res. 924, 141–150 (2002).
    CAS Google Scholar
34. Tupala, E. & Tiihonen, J. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 1221–1247 (2004).
    CAS Google Scholar
35. Kish, S.J. et al. Neuropsychopharmacology 24, 561–567 (2001).
    CAS Google Scholar
36. Robinson, T.E. & Berridge, K.C. Brain Res. Brain Res. Rev. 18, 247–291 (1993).
    CAS Google Scholar
37. Kalivas, P.W. & Duffy, P. Synapse 5, 48–58 (1990).
    CAS Google Scholar
38. Reid, M.S. & Berger, S.P. Neuroreport 7, 1325–1329 (1996).
    CAS Google Scholar
39. Xi, Z.X. et al. J. Pharmacol. Exp. Ther. 303, 608–615 (2002).
    CAS Google Scholar
40. Rouge-Pont, F. et al. J. Neurosci. 22, 3293–3301 (2002).
    CAS Google Scholar
41. Hester, R. & Garavan, H. J. Neurosci. 24, 11017–11022 (2004).
    CAS Google Scholar
42. O'Brien, C.P. Am. J. Psychiatry 162, 1423–1431 (2005).
    Google Scholar
43. Volpicelli, J.R., Alterman, A.I., Hayashida, M. & O'Brien, C.P. Arch. Gen. Psychiatry 49, 876–880 (1992).
    CAS Google Scholar
44. O'Malley, S.S. et al. Arch. Gen. Psychiatry 49, 881–887 (1992).
    CAS Google Scholar
45. Bart, G. et al. Neuropsychopharmacology 30, 417–422 (2005).
    CAS Google Scholar
46. Bart, G. et al. Mol. Psychiatry 9, 547–549 (2004).
    CAS Google Scholar
47. Oslin, D.W. et al. Neuropsychopharmacology 28, 1546–1552 (2003).
    CAS Google Scholar
48. O'Malley, S.S., Krishnan-Sarin, S., Farren, C., Sinha, R. & Kreek, M.J. Psychopharmacology (Berl.) 160, 19–29 (2002).
    CAS Google Scholar
49. Rammes, G. et al. Neuropharmacology 40, 749–760 (2001).
    CAS Google Scholar
50. Haney, M. & Kosten, T.R. Expert Rev. Vaccines 3, 11–18 (2004).
    CAS Google Scholar

Download references